3T

3T Biosciences

South San Francisco, US · 6 known investors

3tbiosciences.com ↗

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.

Founders & leadership

KC

K. Christopher Garcia

Investors · 6

AS

Asset Management CompanyMenlo Park · $500K – $2M

CR

CRV (Charles River Ventures)Bay Area · $250K – $5M

WE

Westlake Village BioPartnersLos Angeles · $100K – $5M

ME

Menlo VenturesreportedSan Francisco · $1M – $20M

OS

OS FundreportedPark Ridge · $1M – $2M

ST

Starlight VenturesreportedMiami · $100K – $3M